![]() |
|
|
![]() |
OxyPharma files patent application for substances for the treatment of rheumatoid arthritis and multiple sclerosisOxyPharma (Stockholm, Sweden) has filed a patent application for the substance strip 803 including other related substances. rook 803 and analogues have in animal ordeals shown very promising results for the treatment of Rheumatoid Arthritis (RA) and Multiple Sclerosis (MS) In addition, OxyPharma plans a financing Want to read the whole article? You can purchase it here. It's quick and easy. Attend the MAP Forum in November! Now that Congres has passed fresh legislation on accounting reform, CPAs around the land have questions about how it will affect their practice... Grasson, Tom American Machinist 07-01-2005 What's beneficial for manufacturing is good for the U Byline: Grasson, Tom ISSN: 10417958 Publication Date: 07-01-20... Historic battlefields provoke a broad range of rejoinders from visitors. This article reports upon the reasons people give for visiting Gettysburg National Military Park and the perceptions ... Anonymous American Machinist 08-01-2000 Reconfigurable module add flexibility to small rooms Byline: Anonymous Volume: 144 Number: 8 ISSN: 10417958 Publi... RESUMEN: En "Legal Reasons, Sources and Gaps", Raz senala que las lagunas juridicas existen solo cuando el derecho habla commit to memory voz incierta o cuando habla consider minutely muchas voces, pero que n... The CSM upon Sept. 24 quoted Andrew Natsios, the USAID's special humanitarian co-ordinator for Sudan, as saying: "We were beginning the arrangement of the conflict in the southern after 21 years of extre... Fibre reinforced plastic make revolves that have a sandwich construction rather than a monolithic design are being unfolded by German researchers. The filament-wound constitutions are designed for ... A great financing environment and an improved local economy have contributed to North Bay's abode building and housing market resound now stretching into the third year. Realtors s... |
![]() |
Articles
|
| . |